New research suggests high-dose intravenous vitamin C may have different biological effects than oral supplements, though its efficacy as a cancer treatment remains unproven.

Decades after Linus Pauling proposed high-dose vitamin C as a cancer treatment, modern research is revisiting the concept. While early studies were dismissed after trials showed oral vitamin C provided no benefit, scientists now distinguish between oral intake and intravenous administration, which achieves significantly higher blood concentrations.

The Difference Between Oral and Intravenous Delivery

The gut has a limited capacity to absorb vitamin C, causing blood levels to plateau regardless of how many tablets are consumed. In contrast, intravenous delivery can raise blood levels to hundreds of times higher than oral doses. At these extreme concentrations, vitamin C functions differently within the body.

Biological Mechanisms and Potential Effects

At high levels, vitamin C can act as a pro-oxidant, helping to generate hydrogen peroxide. Cancer cells, which often operate under high stress and have limited internal cleanup systems, may be uniquely vulnerable to this reactive substance, leading to DNA damage and cell death. Additionally, vitamin C may influence enzymes that regulate how DNA is read and how cells respond to low oxygen levels.

Current Clinical Status

Evidence from human trials remains early and mixed. While some studies suggest intravenous vitamin C may reduce fatigue, pain, and nausea in patients undergoing chemotherapy, there is no definitive proof that it prolongs life. Researchers emphasize that high-dose vitamin C is experimental and should only be administered in supervised medical settings, as it can pose risks to individuals with specific conditions like poor kidney function.